Safeguarding the Global Pharmaceutical Supply Chain: Risk and Cost-Reduction Strategies for Clinical Trial Distribution in Emerging Markets

21 March 2011 by World Courier

In today's highly competitive world of pharmaceutical development, researchers are increasingly turning to locations in Asia, Africa, Latin America and Eastern Europe to conduct critical studies. The benefits are clear - progressive pharmaceutical legislation, a welcoming business environment, low-cost operations, skilled technical personnel and easy access to large pools of treatment-naïve patients.

Despite this impressive potential, the supporting infrastructure in these emerging markets is often fragile. The complexity of the clinical supply chain presents a challenging distribution environment for researchers who must ship large volumes of temperature-sensitive investigational drugs and patient kits worldwide.

Download this free white paper to find out more.